Robert Burns
Stock Analyst at HC Wainwright & Co.
(0.93)
# 3,603
Out of 4,784 analysts
482
Total ratings
24.1%
Success rate
-20.78%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Robert Burns
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| EXEL Exelixis | Reiterates: Buy | $40 | $36.70 | +8.99% | 7 | Mar 27, 2025 | |
| MGNX MacroGenics | Maintains: Neutral | $4 → $2 | $1.26 | +58.73% | 21 | Mar 25, 2025 | |
| YMAB Y-mAbs Therapeutics | Maintains: Buy | $22 → $12 | $4.81 | +149.48% | 20 | Mar 21, 2025 | |
| ELVN Enliven Therapeutics | Maintains: Buy | $37 → $39 | $21.07 | +85.10% | 3 | Mar 21, 2025 | |
| PMVP PMV Pharmaceuticals | Reiterates: Buy | $5 | $1.11 | +350.45% | 11 | Mar 20, 2025 | |
| ALLO Allogene Therapeutics | Maintains: Buy | $9 → $8 | $1.55 | +416.13% | 17 | Mar 19, 2025 | |
| CATX Perspective Therapeutics | Reiterates: Buy | $10 | $2.20 | +354.55% | 2 | Mar 19, 2025 | |
| CRBU Caribou Biosciences | Reiterates: Buy | $9 | $0.94 | +858.36% | 13 | Mar 19, 2025 | |
| BDTX Black Diamond Therapeutics | Maintains: Buy | $11 → $12 | $1.61 | +645.34% | 13 | Mar 18, 2025 | |
| OKUR OnKure Therapeutics | Maintains: Buy | $40 → $34 | $4.46 | +662.33% | 3 | Mar 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $12 → $13 | $12.37 | +5.09% | 20 | Mar 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $11 → $10 | $1.82 | +449.45% | 14 | Mar 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $10 → $5 | $1.05 | +376.19% | 18 | Mar 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $16 | $2.72 | +488.24% | 21 | Mar 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $39 | $18.95 | +105.80% | 8 | Mar 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $13 | $3.53 | +268.27% | 1 | Mar 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $72 → $73 | $37.35 | +95.45% | 19 | Mar 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $13 → $17 | $3.29 | +416.72% | 1 | Feb 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $21 | $6.14 | +242.02% | 22 | Feb 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $74 | $47.41 | +56.09% | 31 | Feb 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $21 → $22 | $10.39 | +111.74% | 16 | Feb 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $7 | $1.70 | +311.76% | 7 | Feb 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $4.18 | - | 4 | Jan 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $35 → $36 | $12.15 | +196.30% | 14 | Jan 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | n/a | $6.53 | - | 13 | Jan 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $42 → $45 | $13.40 | +235.82% | 2 | Jan 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $17 → $14 | $6.48 | +116.05% | 10 | Jan 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $8 | $1.49 | +436.91% | 20 | Jan 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $150 | $94.95 | +57.98% | 37 | Nov 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $13 | $1.47 | +784.35% | 11 | Nov 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $5 | $0.80 | +525.23% | 14 | Nov 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $12 → $11 | $1.24 | +787.10% | 13 | Sep 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $10 | $7.79 | +28.37% | 6 | Aug 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $2.25 | $0.83 | +172.73% | 10 | Aug 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $500 → $200 | $7.61 | +2,528.12% | 5 | May 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $110 → $20 | $0.65 | +2,976.92% | 2 | Mar 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $9.60 | - | 6 | Jan 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $150 | $2.40 | +6,150.00% | 6 | Aug 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $22 | $1.32 | +1,566.67% | 4 | Mar 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $115 → $7 | $0.85 | +724.21% | 7 | Jan 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $12 → $11 | $0.63 | +1,651.03% | 1 | Dec 22, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $250 → $225 | $1.28 | +17,478.13% | 7 | Nov 24, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $25 | $4.56 | +447.83% | 1 | Jun 21, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $19 → $13 | $1.66 | +683.13% | 1 | Jan 7, 2021 |
Exelixis
Mar 27, 2025
Reiterates: Buy
Price Target: $40
Current: $36.70
Upside: +8.99%
MacroGenics
Mar 25, 2025
Maintains: Neutral
Price Target: $4 → $2
Current: $1.26
Upside: +58.73%
Y-mAbs Therapeutics
Mar 21, 2025
Maintains: Buy
Price Target: $22 → $12
Current: $4.81
Upside: +149.48%
Enliven Therapeutics
Mar 21, 2025
Maintains: Buy
Price Target: $37 → $39
Current: $21.07
Upside: +85.10%
PMV Pharmaceuticals
Mar 20, 2025
Reiterates: Buy
Price Target: $5
Current: $1.11
Upside: +350.45%
Allogene Therapeutics
Mar 19, 2025
Maintains: Buy
Price Target: $9 → $8
Current: $1.55
Upside: +416.13%
Perspective Therapeutics
Mar 19, 2025
Reiterates: Buy
Price Target: $10
Current: $2.20
Upside: +354.55%
Caribou Biosciences
Mar 19, 2025
Reiterates: Buy
Price Target: $9
Current: $0.94
Upside: +858.36%
Black Diamond Therapeutics
Mar 18, 2025
Maintains: Buy
Price Target: $11 → $12
Current: $1.61
Upside: +645.34%
OnKure Therapeutics
Mar 18, 2025
Maintains: Buy
Price Target: $40 → $34
Current: $4.46
Upside: +662.33%
Mar 10, 2025
Maintains: Neutral
Price Target: $12 → $13
Current: $12.37
Upside: +5.09%
Mar 10, 2025
Maintains: Buy
Price Target: $11 → $10
Current: $1.82
Upside: +449.45%
Mar 7, 2025
Maintains: Buy
Price Target: $10 → $5
Current: $1.05
Upside: +376.19%
Mar 7, 2025
Reiterates: Buy
Price Target: $16
Current: $2.72
Upside: +488.24%
Mar 7, 2025
Reiterates: Buy
Price Target: $39
Current: $18.95
Upside: +105.80%
Mar 3, 2025
Initiates: Buy
Price Target: $13
Current: $3.53
Upside: +268.27%
Mar 3, 2025
Maintains: Buy
Price Target: $72 → $73
Current: $37.35
Upside: +95.45%
Feb 28, 2025
Maintains: Buy
Price Target: $13 → $17
Current: $3.29
Upside: +416.72%
Feb 26, 2025
Reiterates: Buy
Price Target: $21
Current: $6.14
Upside: +242.02%
Feb 24, 2025
Reiterates: Buy
Price Target: $74
Current: $47.41
Upside: +56.09%
Feb 13, 2025
Maintains: Buy
Price Target: $21 → $22
Current: $10.39
Upside: +111.74%
Feb 10, 2025
Reiterates: Buy
Price Target: $7
Current: $1.70
Upside: +311.76%
Jan 30, 2025
Downgrades: Neutral
Price Target: n/a
Current: $4.18
Upside: -
Jan 29, 2025
Maintains: Buy
Price Target: $35 → $36
Current: $12.15
Upside: +196.30%
Jan 28, 2025
Reiterates: Neutral
Price Target: n/a
Current: $6.53
Upside: -
Jan 27, 2025
Maintains: Buy
Price Target: $42 → $45
Current: $13.40
Upside: +235.82%
Jan 14, 2025
Maintains: Buy
Price Target: $17 → $14
Current: $6.48
Upside: +116.05%
Jan 6, 2025
Reiterates: Buy
Price Target: $8
Current: $1.49
Upside: +436.91%
Nov 18, 2024
Reiterates: Buy
Price Target: $150
Current: $94.95
Upside: +57.98%
Nov 8, 2024
Reiterates: Buy
Price Target: $13
Current: $1.47
Upside: +784.35%
Nov 8, 2024
Reiterates: Buy
Price Target: $5
Current: $0.80
Upside: +525.23%
Sep 5, 2024
Maintains: Neutral
Price Target: $12 → $11
Current: $1.24
Upside: +787.10%
Aug 23, 2024
Reiterates: Buy
Price Target: $10
Current: $7.79
Upside: +28.37%
Aug 19, 2024
Reiterates: Buy
Price Target: $2.25
Current: $0.83
Upside: +172.73%
May 8, 2024
Maintains: Buy
Price Target: $500 → $200
Current: $7.61
Upside: +2,528.12%
Mar 21, 2024
Maintains: Buy
Price Target: $110 → $20
Current: $0.65
Upside: +2,976.92%
Jan 8, 2024
Downgrades: Neutral
Price Target: n/a
Current: $9.60
Upside: -
Aug 8, 2023
Reiterates: Buy
Price Target: $150
Current: $2.40
Upside: +6,150.00%
Mar 17, 2023
Reiterates: Buy
Price Target: $22
Current: $1.32
Upside: +1,566.67%
Jan 24, 2023
Downgrades: Neutral
Price Target: $115 → $7
Current: $0.85
Upside: +724.21%
Dec 22, 2021
Maintains: Buy
Price Target: $12 → $11
Current: $0.63
Upside: +1,651.03%
Nov 24, 2021
Maintains: Buy
Price Target: $250 → $225
Current: $1.28
Upside: +17,478.13%
Jun 21, 2021
Assumes: Buy
Price Target: $25
Current: $4.56
Upside: +447.83%
Jan 7, 2021
Maintains: Buy
Price Target: $19 → $13
Current: $1.66
Upside: +683.13%